Javascript must be enabled to continue!
PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI
View through CrossRef
AbstractThis comparative observational study aimed to validate an online Patient‐oriented Psoriasis Area and Severity Index (PO‐PASI) by comparing it against the Psoriasis Area and Severity Index (PASI), of 97 adult participants with chronic plaque psoriasis. Pearson's correlation coefficient of 0.866 (P‐value = 0.0001) showed a strong positive linear correlation, and interclass correlation coefficients [ICC scores = 0.864 [95% confidence intervals (CIs) (0.803 < ICC < 0.907)]] suggest an interrater reliability of ‘good’ to ‘excellent’ when comparing PO‐PASI to the PASI score. Additionally, we compared PO‐PASI and PASI with DLQI and demonstrated an overall stronger positive correlation between PO‐PASI and DLQI when compared to PASI.
Title: PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI
Description:
AbstractThis comparative observational study aimed to validate an online Patient‐oriented Psoriasis Area and Severity Index (PO‐PASI) by comparing it against the Psoriasis Area and Severity Index (PASI), of 97 adult participants with chronic plaque psoriasis.
Pearson's correlation coefficient of 0.
866 (P‐value = 0.
0001) showed a strong positive linear correlation, and interclass correlation coefficients [ICC scores = 0.
864 [95% confidence intervals (CIs) (0.
803 < ICC < 0.
907)]] suggest an interrater reliability of ‘good’ to ‘excellent’ when comparing PO‐PASI to the PASI score.
Additionally, we compared PO‐PASI and PASI with DLQI and demonstrated an overall stronger positive correlation between PO‐PASI and DLQI when compared to PASI.
Related Results
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment
Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment
AbstractBackground The US National Psoriasis Foundation recently recommended that PASI 50 and PASI 75 response rates be used in clinical trials to enable comparisons across studie...
Bio‐experienced psoriasis patients treated with anti‐interleukin monoclonal antibodies are less likely to achieve PASI 90, PASI 100, PASI ≤ 1 and ≤3: Results from a cohort of 305 patients
Bio‐experienced psoriasis patients treated with anti‐interleukin monoclonal antibodies are less likely to achieve PASI 90, PASI 100, PASI ≤ 1 and ≤3: Results from a cohort of 305 patients
AbstractBackgroundMonoclonal antibodies (mAbs) directed against tumour necrosis factor alpha (TNF‐α) and interleukin (IL)‐17 and ‐23 represent the ultimate therapeutic strategy in ...
PATIENT-CLINICIAN RELATIONSHIPS IN HOME HEALTH CARE
PATIENT-CLINICIAN RELATIONSHIPS IN HOME HEALTH CARE
Abstract
Patient-clinician relationships are fundamental attributes of high-quality home health care (HHC); yet little is known about patient-clinician relationships...
Eliciting Insights From Chat Logs of the 25X5 Symposium to Reduce Documentation Burden: Novel Application of Topic Modeling (Preprint)
Eliciting Insights From Chat Logs of the 25X5 Symposium to Reduce Documentation Burden: Novel Application of Topic Modeling (Preprint)
BACKGROUND
Addressing clinician documentation burden through “targeted solutions” is a growing priority for many organizations ranging from government and a...
Eliciting Insights From Chat Logs of the 25X5 Symposium to Reduce Documentation Burden: Novel Application of Topic Modeling
Eliciting Insights From Chat Logs of the 25X5 Symposium to Reduce Documentation Burden: Novel Application of Topic Modeling
Background
Addressing clinician documentation burden through “targeted solutions” is a growing priority for many organizations ranging from government and academia to i...
Effectiveness of Tildrakizumab in the Long‐Term Treatment of Plaque Psoriasis: A Retrospective, Multicenter Analysis Over 76 Weeks
Effectiveness of Tildrakizumab in the Long‐Term Treatment of Plaque Psoriasis: A Retrospective, Multicenter Analysis Over 76 Weeks
Background: Psoriasis is a chronic inflammatory disease affecting skin and patients’ quality of life. Tildrakizumab is an IL‐23p19‐inhibitor approved for treatment of moderate‐to‐s...
A System Dynamics Model for Effects of Workplace Violence and Clinician Burnout on Agitation Management in the Emergency Department
A System Dynamics Model for Effects of Workplace Violence and Clinician Burnout on Agitation Management in the Emergency Department
ABSTRACTBackgroundOver 1.7 million episodes of agitation occur annually across the United States in emergency departments (EDs), some of which lead to workplace assaults on clinici...

